CAS 1365060-22-5

Formule : C11H9ClN2O2S2

InChI : InChI=1S/C11H9ClN2O2S2/c12-10-7(5-1-2-5)8-9(18-10)11(14-4-13-8)17-3-6(15)16/h4-5H,1-3H2,(H,15,16)

Code InChI : LJYRIWUQISYYHA-UHFFFAOYSA-N

SMILES : C1CC1C2=C(SC3=C2N=CN=C3SCC(=O)O)Cl

LP-922056

CAS : 1365060-22-5

LP-922056

Formule : C₁₁H₉ClN₂O₂S₂

Degré de pureté : ≥98%

Masse moléculaire : 300.78

Ref: 54-BUP02908

LP-922056

CAS : 1365060-22-5

LP-922056 is an inhibitor of Notum Pectinacetylesterase with EC50 values of 21 nM, 55 nM for human and mouse, respectively.

Formule : C₁₁H₉ClN₂O₂S₂

Degré de pureté : 99.84%

Couleur et forme : White Solid

Masse moléculaire : 300.784

Ref: TM-T38776

2-((6-Chloro-7-Cyclopropylthieno[3,2-D]Pyrimidin-4-Yl)Thio)Acetic Acid

CAS : 1365060-22-5

Formule : C₁₁H₉ClN₂O₂S₂

Degré de pureté : 98%

Masse moléculaire : 300.7844

Ref: IN-DA009XT5

LP 922056

CAS : 1365060-22-5

LP 922056 is a drug that inhibits the dopamine transporter and has been shown to be effective in treating Parkinson's disease. It has also been shown to be effective in treating osteoporosis and osteopenia, which are characterized by low bone mineral density and increased risk of fracture. LP 922056 increases bone mineral density by inhibiting the reuptake of dopamine from the synapse, thereby increasing dopamine levels in the brain. This increase in dopamine levels stimulates new bone formation and leads to an increase in bone mineral density.

Formule : C₁₁H₉ClN₂O₂S₂

Degré de pureté : Min. 95%

Masse moléculaire : 300.8 g/mol

Ref: 3D-QEC06022